Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Ramkhamhaeng Hospital Public Company Limited (RAM.BK)
THB17.90
-0.10 (-0.56%)
TH SET Healthcare Medical - Care Facilities
Address
436 Ramkhamhaeng Road 10240
Bangkok, TH
Bangkok, TH
CEO
Rukkagee Kanjanapitak
Website
ram-hosp.co.th
IPO
2000-01-04
ISIN TH0259A10Z01
Description
Ramkhamhaeng Hospital Public Company Limited and its associated entities provide healthcare services through their private hospital network throughout Thailand. The hospital complex comprises three patient buildings, collectively offering approximately 485 beds. Additionally, the company is involved in the sale of medical equipment and instruments. Established in 1988, its headquarters are situated in Bangkok, Thailand.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
THB17.90
-0.10 (-0.56%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
41.4K
Beta
-0.08
Float Shares
195.23M
Free Float %
16.3%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | -0.54% | +0.55% | -2.66% | +2.23% | -0.54% | -1.61% | -60.65% | -34.64% | -33.45% | +3,064.94% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
17.90
DCF (Unlevered)
85.39
+377.0%
DCF (Levered)
58.36
+226.0%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
0% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 2 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
1.21
Distress
Piotroski F-Score
6 / 9
Average
MOAT Score
2 / 10
No MOAT
Composite Rating
A-
Overall Score
4 / 5
High
DCF Score
5 / 5
High
ROE Score
4 / 5
High
ROA Score
4 / 5
High
D/E Score
1 / 5
Low
P/E Score
3 / 5
Medium
P/Book Score
4 / 5
High
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Care Facilities: +10.2%+49.5% ★ Q1'26: +100.9% (vs Q1'25)
-
EPS growth Medical - Care Facilities: +19.2%+282.0% ★ Q1'26: -31.0% (vs Q1'25)
-
FCF margin FCF growth · Medical - Care Facilities: +32.0%+1.0% Q1'26: +5.3% (vs Q1'25)
-
EBIT margin Medical - Care Facilities: +11.3%+8.3% Q1'26: +10.0% (vs Q1'25)
-
ROIC Medical - Care Facilities: +6.8%+1.9% Q1'26: +3.1% (vs Q1'25)
-
Share dilution Medical - Care Facilities: +0.0%+0.0% Q1'26: +0.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Care Facilities: 0.99×6.78× Q1'26: 4.02× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 2 Rev. Ana. 2 EPS Ana. |
Dec 2027 2 Rev. Ana. 2 EPS Ana. |
Dec 2028 2 Rev. Ana. 2 EPS Ana. |
|---|---|---|---|---|---|---|---|---|
| Revenue |
12.66B
est: 11.55B (+9.6%)
|
10.69B
est: 10.42B (+2.6%)
|
9.63B
est: 9.63B (+0.0%)
|
9.87B
est: 9.67B (+2.1%)
|
14.75B
est: 13.22B (+11.5%)
|
22.08B
21.70B – 22.46B
+66.9% YoY
|
22.96B
22.80B – 23.12B
+4.0% YoY
|
23.89B
23.60B – 24.17B
+4.0% YoY
|
| EBITDA |
6.95B
est: 3.69B (+88.6%)
|
2.90B
est: 3.32B (-12.7%)
|
2.35B
est: 2.86B (-17.7%)
|
2.35B
est: 2.87B (-18.2%)
|
2.69B
est: 3.93B (-31.6%)
|
6.56B
6.45B – 6.67B
+66.9% YoY
|
6.82B
6.77B – 6.87B
+4.0% YoY
|
7.10B
7.01B – 7.18B
+4.0% YoY
|
| EBIT |
6.14B
est: 2.46B (+149.6%)
|
1.91B
est: 2.22B (-14.1%)
|
1.32B
est: 1.96B (-32.6%)
|
1.31B
est: 1.96B (-33.2%)
|
1.22B
est: 2.69B (-54.4%)
|
4.48B
4.41B – 4.56B
+66.9% YoY
|
4.66B
4.63B – 4.70B
+4.0% YoY
|
4.85B
4.79B – 4.91B
+4.0% YoY
|
| Net Income |
4.17B
est: 4.07B (+2.5%)
|
2.17B
est: 2.38B (-8.5%)
|
1.55B
est: 1.43B (+8.3%)
|
727.83M
est: 1.04B (-29.9%)
|
2.80B
est: 869.68M (+221.7%)
|
1.34B
1.19B – 1.49B
+54.4% YoY
|
1.46B
1.30B – 1.63B
+8.8% YoY
|
1.64B
1.40B – 1.87B
+12.3% YoY
|
| SGA |
1.38B
est: 1.64B (-16.3%)
|
1.51B
est: 1.48B (+2.2%)
|
1.56B
est: 1.38B (+12.9%)
|
1.36B
est: 1.39B (-1.9%)
|
2.46B
est: 1.90B (+30.0%)
|
3.17B
3.11B – 3.22B
+66.9% YoY
|
3.29B
3.27B – 3.32B
+4.0% YoY
|
3.42B
3.38B – 3.47B
+4.0% YoY
|
| EPS |
3.48
est: 3.39 (+2.7%)
|
1.81
est: 1.98 (-8.6%)
|
1.29
est: 1.19 (+8.0%)
|
0.61
est: 0.87 (-29.5%)
|
2.33
est: 0.72 (+221.5%)
|
1.12
0.99 – 1.24
+53.9% YoY
|
1.22
1.08 – 1.36
+9.4% YoY
|
1.37
1.17 – 1.56
+11.9% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-21 | A- | 4/5 | 5/5 | 4/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-20 | A- | 4/5 | 5/5 | 4/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-19 | A- | 4/5 | 5/5 | 4/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-18 | A- | 4/5 | 5/5 | 4/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-15 | A- | 4/5 | 5/5 | 4/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-14 | A- | 4/5 | 5/5 | 4/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-13 | A- | 4/5 | 5/5 | 4/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-12 | A- | 4/5 | 5/5 | 4/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-11 | A- | 4/5 | 5/5 | 4/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-08 | A | 4/5 | 5/5 | 4/5 | 4/5 | 1/5 | 4/5 | 4/5 |
| 2026-05-07 | A | 4/5 | 5/5 | 4/5 | 4/5 | 1/5 | 4/5 | 4/5 |
| 2026-05-06 | A | 4/5 | 5/5 | 4/5 | 4/5 | 1/5 | 4/5 | 4/5 |
| 2026-05-05 | A | 4/5 | 5/5 | 4/5 | 4/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-30 | A | 4/5 | 5/5 | 4/5 | 4/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-29 | A | 4/5 | 5/5 | 4/5 | 4/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-28 | A | 4/5 | 5/5 | 4/5 | 4/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-27 | A | 4/5 | 5/5 | 4/5 | 4/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-24 | A | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-23 | A | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-22 | A | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-21 | A | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-20 | A | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-17 | A | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-16 | A | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
11.92B
OE per share TTM
9.93
Owner's Yield
54.26%
Maintenance CapEx ratio
1,331.83%
Maint CapEx / Avg PPE
139.0%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
ETF Ownership
Top ETFs holding this stock
This company is not held by any ETF in our universe.
Insider Activity
Insider Activity — Latest Quarter
No insider activity available.
Insider buys vs sells (history)
Insider history not available.
Recent insider transactions
No recent insider transactions.
Executive team
Top executives
EBIT / Employee
641.2K
Shares Outstanding
1.20B
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Talit Chuen-Im | Executive VP of Northeastern Hospital Group & Executive Director | 1M | male |
| Siripong Luengvarinkul | Chief Executive Officer of Group 2 Hospitals & Executive Director | 1M | — |
| Suthee Leelasetakul | Chief Executive Officer of RAM 1 & Executive Director | 1M | — |
| Rukkagee Kanjanapitak | Group Chief Executive Officer & Executive Director | 1M | — |
| Phitchaya Somburanasin | Executive Chairman | 1M | — |
| Jermpol Bhumitrakul | Group Chief Operating Officer, Chief Executive Officer of Hospital Group 1 & Executive Director | 1M | — |
| Tassawan Sirivongs | Executive Director | 360.0K | female |
| Pumipat Chatnoraset | Chief Financial Officer | — | male |
| Mingphimuk Limcharoonsak | Head of Internal Audit | — | male |
| Pakkawat Kitsirikarn | Head of Investor Relations | — | male |
| Pramuk Unachak | Executive Vice President of Northern Hospital Group | — | — |
| Chanyawat Watthanaphongsaphat | Head of Compliance & Company Secretary | — | female |
ESG Score History
No data available for this company.
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for RAM.BK
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
